This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Vertex chief operating officer Stuart Arbuckle plans to retire in July, the comp...
A federal court in Massachusetts temporarily blocked the Trump administration’s ...
German pharma company Merck KGaA confirmed that it is in talks to acquire Spring...
Eli Lilly is betting up to $630 million on an experimental MASH treatment from a...
Twenty-two state attorneys general sued the Trump administration on Monday in a ...
Novo Nordisk hit back at telehealth company Hims’ controversial Super Bowl comme...
Several brand-name drugmakers believe they will withstand any drug pricing impac...
Novo Nordisk hit back at telehealth company Hims’ controversial Super Bowl comme...
Boehringer Ingelheim said its experimental treatment for a chronic lung disease ...
Plus, news about Caliway Biopharmaceuticals, Orca Bio, Alterity Therapeutics and...
Roche's $8 billion InterMune acquisition, disclosed a decade ago, is now being h...
Pliant Therapeutics has slammed the brakes on enrollment and dosing in a mid-sta...
Plus, news about X4 Pharmaceuticals, Viracta Therapeutics, Crown Laboratories, Q...
It took one month for Johnson & Johnson to secure its $14 billion acquisition of...
AstraZeneca has terminated all development of vemircopan, the oral factor D inhi...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...